Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Misuse and Smoking Cessation
NCT03857139Phase 4Withdrawn
- Sponsor
- University of Houston
- Start
- Dec 2020
- Primary completion
- Jan 2022
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nicotine patch in Tobacco Use Disorder (TUD), sponsored by University of Houston. Primary endpoint: Point Prevalence Abstinence. Planned start Dec 2020; status: withdrawn.
02
Drugs
nicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03857139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03857139.